Qualifying Microphysiological Systems for Highly Specific Contexts of Use as Bonified Drug Development Tools
Time: 2:15 pm
day: Day 1
Details:
- Discussing the Translational Centers for MPS (TraCe MPS) Program’s role in supporting well-validated MPS to be submitted to the FDA ISTAND Program
- Aligning on recent updates from the Translational Centers for MPS Program at NIH
- Building highly specific context-of-use cases of MPS across different phases of drug development to facilitate regulatory approval
